Sam Chun Dang Pharm000250
Sam Chun Dang Pharm (000250) Amended Material Information, 2026-10-01
Filing date ·
Sam Chun Dang Pharm amended its disclosure of the exclusive distribution rights contract in Canada for a macular degeneration treatment biosimilar SCD411.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.